Comparing HICT and MICT for Health Improvements in Overweight Young Adults
Launched by INDONESIA UNIVERSITY · Jun 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different types of exercise programs can help overweight young men improve their health. Specifically, it compares high-intensity circuit training (which involves short bursts of intense exercise) to moderate-intensity continuous training (like steady jogging). The goal is to see which method better improves body weight, heart health, and other important health markers, while also looking at how much participants enjoy the exercises and stick to the program over 12 weeks.
To participate, men aged 18 to 30 who are overweight (with a body mass index between 23 and 24.9) and haven't been active for the past six months may be eligible. Participants should be willing to commit to the exercise program for the entire duration and not engage in other exercise activities during this time. They will be asked to keep track of their food intake and physical activity each month. It's important to note that individuals with certain health conditions, those who smoke, or those who have had recent injuries may not be eligible. Overall, participants can expect to engage in a structured exercise program, receive support, and contribute to valuable research that could help improve health outcomes for young adults.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Overweight (BMI 23-24.9 kg/m2)
- • Physically inactive in the last 6 months before the study (\<150 minutes of moderate-intensity activity and \<75 minutes of high-intensity activity)
- • Willing to participate in exercise program for 12 weeks
- • No other exercise program during the study period
- Exclusion Criteria:
- • Smoking
- • Medical comorbidities (diabetes mellitus, hypertension, cardiovascular disease, asthma, dyslipidaemia, epilepsy)
- • History of musculoskeletal injuries or health problems related to exercise in the last 1 year
- • Dropout Criteria
- • Resigning
- • Not participating in the endline assessment
- • Not participating in the exercise program for 2 consecutive weeks
- • Experiencing injury or health problems that led to the inability to participate in the program for 2 consecutive weeks
About Indonesia University
Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jakarta Pusat, Dki Jakarta, Indonesia
Patients applied
Trial Officials
Nani C Sudarsono, Doctor
Principal Investigator
Fakultas Kedokteran Universitas Indonesia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported